Epidarex Capital
Overview
Epidarex Capital (formerly Rock Spring Ventures) invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today's healthcare market.
Investment Focus
- Early-stage life science and health technology companies
- Innovations spun out of universities
- Companies addressing major unmet needs in the global healthcare market
Portfolio Companies
Reach Epidarex Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Epidarex Capital
What sectors does Epidarex Capital invest in?
Epidarex Capital invests in Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Personalized Medicine, and is based in Bethesda, Maryland, United States. Epidarex Capital is listed as a vc in the ConnectSafely investor database.
What stage does Epidarex Capital invest at?
Epidarex Capital backs companies at Seed, Early Stage and Growth, writing cheques of 2M - 5M.
Which regions does Epidarex Capital invest in?
Epidarex Capital invests across United States and United Kingdom.
Who are the partners at Epidarex Capital?
Team members listed for Epidarex Capital include Kyparissia Sirinakis (Co-Founder & Managing Partner) and Sinclair Dunlop (Managing Partner).
What companies has Epidarex Capital invested in?
Epidarex Capital's portfolio includes NodThera, Theolytics and Sirakoss.
How do I contact Epidarex Capital?
Epidarex Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
